Artificial Intelligence (AI) in Medical Diagnostics Market By Diseases (Oncology, Cardiovascular diseases, Neurological Disorders, Respiratory Diseases, Diabetes, and Infectious Diseases And By Application (Imaging Diagnostics, Genomic Diagnostics, Laboratory Diagnostics, Preventive Diagnostics, and Clinical Decision Support), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025–2035

Published Date: Sep 2024 | Report ID: MI1048 | 225 Pages


Report Coverage:

By Application

  • Imaging Diagnostics
  • Genomic Diagnostics
  • Laboratory Diagnostics
  • Preventive Diagnostics
  • Clinical Decision Support

By Disease

  • Oncology
  • Cardiovascular diseases
  • Neurological Disorders
  • Respiratory Diseases
  • Diabetes
  • Infectious Diseases
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

List of Companies

  • NVIDIA Corporation
  • Siemens Healthineers
  • GE HealthCare
  • Google
  • Microsoft
  • Intel Corporation
  • IBM Watson Health
  • Philips Healthcare
  • Digital Diagnostics Inc.
  • HeartFlow, Inc.
  • Butterfly Network, Inc
  • Zebra Medical Vision
  • Aidence
  • Enlitic, Inc.
  • Icometrix

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.